Development Forecast by JD-003
Purposeβ
This document is a forecast of the development projects planned by JD-003 for the next years. It is intended to be used for planning grants and funding applications.
Keep in mind that the projects led by JD-005, JD-007, and JD-004 may be overlapping with this planning, since the JD-003 supervises these departments. Be sure to investigate their specific plans and timelines.
Projectsβ
Grants and Funding Planning
Overall Summary (Filtered)
ENS (Esquema Nacional de Seguridad) Certification
[HIGH]Achieve ENS certification to comply with Spanish national security requirements for public healthcare contracts
ISO 27001 Information Security Management System
[HIGH]Implement and certify ISO 27001 ISMS for global information security compliance
SOC 2 Type II Certification
[MEDIUM]Achieve SOC 2 Type II certification for US market trust and compliance
FDA-Cleared Malignancy Detection Device
[HIGH]Develop and certify new medical device focused on skin malignancy detection for US market
FDA 510(k) Clearance Process
[HIGH]Obtain FDA clearance for malignancy detection device
Large Language Model Integration
[MEDIUM]Integrate LLM capabilities for natural language interpretation of diagnostic results
Advanced Features and Reporting
[MEDIUM]Expand product capabilities with new endpoints for referrals, urgency scoring, entropy analysis
- All cost estimations are in EUR
- Hours are calculated based on 8-hour work days
- Last updated: 2025-01-18
- Created by: JD-003
Export Optionsβ
This data can be exported from the JSON file at grants-data.json
for use in grant applications, financial planning, and resource allocation. The component above provides filtering and summary capabilities to help identify projects matching specific grant criteria.
Strategic Alignmentβ
The projects listed above align with Legit.Health's strategic goals of:
- Market Expansion: Entering the US market through FDA certification
- Security Compliance: Achieving ENS, ISO 27001, and SOC 2 certifications
- Product Innovation: Integrating LLM capabilities and expanding features
- Regulatory Compliance: Meeting requirements for different markets
Funding Sources to Considerβ
- EU Horizon Europe: For AI and medical device innovation
- Spanish CDTI: For R&D and international expansion
- NIH SBIR/STTR: For US market clinical validation
- EIC Accelerator: For scaling and market deployment
- Regional grants: Basque Government innovation programs